In the investigations, which began in November 2015 and have continued into early 2016, federal officials claim that the dispensing of compounded drugs has increased exponentially without appropriate medical justification and without adherence to government regulations. They note, for example, that Tricare paid out some $1.75 billion for compound drugs in 2015, 18 times the amount it paid just three years earlier. Even if you are a compounding pharmacy that plays completely by the rules, your business still may be in the crosshairs of the DOJ investigations.